North America ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others

Summary

GlobalData’s new report, “North America ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others” provides key market data on the North America ENT Devices market – Canada and United States. The report provides value (USD million) data for all the market categories – Diagnostic Devices, Hearing Aid Devices, Hearing Implants, Nasal Splints and Voice Prosthesis. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Countries covered include Canada and United States.
- Market size and company share data for ENT Devices market categories – Diagnostic Devices, Hearing Aid Devices, Hearing Implants, Nasal Splints and Voice Prosthesis.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the North America ENT Devices market..
- Key players covered include Starkey Hearing Technologies, Inc., Sonova Holding AG, William Demant Holding A/S, Siemens Healthcare, Cochlear Limited, GN ReSound A/S and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the North America ENT Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table Of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What is This Report About? 8
3 ENT Devices In North America 9
3.1 ENT Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 9
3.2 ENT Devices, North America, Overall Revenue ($m), USD Constant, 2004-2018 10
3.3 ENT Devices, North America, Company share (2010-2011) 16
4 ENT Devices In United States 18
4.1 ENT Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018 18
4.2 ENT Devices, United States, Distribution Share (2010-2011) 23
4.2.1 Diagnostic Devices, United States, Distribution Share (2010-2011) 23
4.2.2 Hearing Aid Devices, United States, Distribution Share (2010-2011) 23
4.2.3 Hearing Implants, United States, Distribution Share (2010-2011) 24
4.2.4 Nasal Splints, United States, Distribution Share (2010-2011) 24
4.2.5 Voice Prosthesis, United States, Distribution Share (2010-2011) 25
4.3 ENT Devices, United States, Company Share (2010-2011) 26
4.3.1 ENT Devices, United States, Company Share (2010-2011) 26
4.3.2 Diagnostic Devices, United States, Company Share (2010-2011) 28
4.3.3 Hearing Aid Devices, United States, Company Share (2010-2011) 30
4.3.4 Hearing Implants, United States, Company Share (2010-2011) 32
4.3.5 Voice Prosthesis, United States, Company Share (2010-2011) 33
5 ENT Devices In Canada 34
5.1 ENT Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018 34
5.2 ENT Devices, Canada, Distribution Share (2010-2011) 40
5.2.1 Diagnostic Devices, Canada, Distribution Share (2010-2011) 40
5.2.2 Hearing Aid Devices, Canada, Distribution Share (2010-2011) 40
5.2.3 Hearing Implants, Canada, Distribution Share (2010-2011) 41
5.2.4 Nasal Splints, Canada, Distribution Share (2010-2011) 41
5.2.5 Voice Prosthesis, Canada, Distribution Share (2010-2011) 42
5.3 ENT Devices, Canada, Company Share (2010-2011) 43
5.3.1 ENT Devices, Canada, Company Share (2010-2011) 43
5.3.2 Diagnostic Devices, Canada, Company Share (2010-2011) 45
5.3.3 Hearing Aid Devices, Canada, Company Share (2010-2011) 47
5.3.4 Hearing Implants, Canada, Company Share (2010-2011) 49
5.3.5 Voice Prosthesis, Canada, Company Share (2010-2011) 50
6 Overview of Key Companies in North America ENT Devices Market 51
6.1 William Demant Holding A/S 51
6.1.1 Company Overview 51
6.1.2 Share in the North America ENT Devices Market 51
6.2 Starkey Hearing Technologies, Inc. 52
6.2.1 Company Overview 52
6.2.2 Share in the North America ENT Devices Market 52
6.3 Sonova Holding AG 53
6.3.1 Company Overview 53
6.3.2 Share in the North America ENT Devices Market 53
6.4 Siemens Healthcare 54
6.4.1 Company Overview 54
6.4.2 Share in the North America ENT Devices Market 54
6.5 Cochlear Limited 55
6.5.1 Company Overview 55
6.5.2 Share in the North America ENT Devices Market 55
6.6 GN ReSound A/S 56
6.6.1 Company Overview 56
6.6.2 Share in the North America ENT Devices Market 56
6.7 Widex A/S 57
6.7.1 Company Overview 57
6.8 MED-EL 57
6.8.1 Company Overview 57
6.9 Natus Medical Incorporated 57
6.9.1 Company Overview 57
6.10 Welch Allyn Inc. 57
6.10.1 Company Overview 57
6.11 Atos Medical AB 58
6.11.1 Company Overview 58
6.12 InHealth 58
6.12.1 1.1.1 Company Overview 58
7 ENT Devices Market Pipeline Products 59
8 Financial Deals Landscape 60
8.1 Acquisition 60
8.1.1 Audiology Distribution Completes Acquisition Of HearUSA For $71 Million 60
8.2 Partnerships 62
8.2.1 Aircraft Medical Enters Into Distribution Agreement With Covidien For McGRATH MAC Video Laryngoscope 62
9 Recent Developments 64
9.1 Legal and Regulatory 64
9.1.1 Jan 19, 2012: Hausfeld Files Class Action Suit Against Siemens Hearing Instruments Alleging Violations Of Federal Securities Laws 64
9.1.2 Nov 28, 2011: ArthroCare Announces Agreement In Principle To Settle Securities Class Action 65
9.2 Government and Public Interest 65
9.2.1 Oct 13, 2011: Better Hearing Institute Warns On Over-The-Counter Hearing Aid Devices 65
9.2.2 Sep 30, 2011: Sonova Strengthens Unitron Brand And Reviews Middle Ear Implant Activities 66
9.2.3 Jun 27, 2011: Hearing Aid Wearers Restrict Everyday Activities Due To Hearing Device Limitations: Siemens Hearing Instruments 67
9.2.4 Jun 20, 2011: Teleflex Resolves FDA Corporate Warning Letter 68
10 Appendix 69
10.1 Definitions of Markets Covered in the Report 70
10.1.1 ENT Devices 70
10.2 Research Methodology 71
10.3 Secondary Research 71
10.4 Primary Research 72
10.5 Models 72
10.6 Forecasts 73
10.7 Expert Panels 73
10.8 GlobalData Consulting 73
10.9 Currency Conversion 73
10.10 Contact Us 74
10.11 Disclaimer 74

List of Tables

Table 1: ENT Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 9
Table 2: ENT Devices, North America, Overall Revenue ($m), USD Constant, 2004-2018 10
Table 3: ENT Devices, North America, Cross-Category Analysis, 2004-2018 11
Table 4: ENT Devices, North America, Overall Revenue ($m), USD Constant, Historic, 2004-2011 13
Table 5: ENT Devices, North America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 15
Table 6: ENT Devices, North America, Company share by Revenue ($m), USD Constant, 2010-2011 17
Table 7: ENT Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018 18
Table 8: ENT Devices, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20
Table 9: ENT Devices, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22
Table 10: Diagnostic Devices, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 23
Table 11: Hearing Aid Devices, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 23
Table 12: Hearing Implants, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 24
Table 13: Nasal Splints, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 24
Table 14: Voice Prosthesis, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 25
Table 15: ENT Devices, United States, Company Share, USD Constant, (2010-2011) 27
Table 16: Diagnostic Devices, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 29
Table 17: Hearing Aid Devices, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 31
Table 18: Hearing Implants, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 32
Table 19: Voice Prosthesis, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 33
Table 20: ENT Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018 35
Table 21: ENT Devices, Canada, Overall Revenue ($m), USD Constant, Historic, 2004-2011 37
Table 22: ENT Devices, Canada, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 39
Table 23: Diagnostic Devices, Canada, Distribution Share by Revenue ($m), USD Constant, 2010-2011 40
Table 24: Hearing Aid Devices, Canada, Distribution Share by Revenue ($m), USD Constant, 2010-2011 40
Table 25: Hearing Implants, Canada, Distribution Share by Revenue ($m), USD Constant, 2010-2011 41
Table 26: Nasal Splints, Canada, Distribution Share by Revenue ($m), USD Constant, 2010-2011 41
Table 27: Voice Prosthesis, Canada, Distribution Share by Revenue ($m), USD Constant, 2010-2011 42
Table 28: ENT Devices, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011 44
Table 29: Diagnostic Devices, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011 46
Table 30: Hearing Aid Devices, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011 48
Table 31: Hearing Implants, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011 49
Table 32: Voice Prosthesis, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011 50
Table 33: ENT Devices Market Pipeline Products 59
Table 34: Audiology Distribution Completes Acquisition Of HearUSA For $71 Million 60
Table 35: Aircraft Medical Enters Into Distribution Agreement With Covidien For McGRATH MAC Video Laryngoscope 62

List of Figures

Figure 1: ENT Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 9
Figure 2: ENT Devices, North America, Overall Revenue ($m), USD Constant, 2004-2018 10
Figure 3: ENT Devices, North America, Cross-Category Analysis, 2004-2018 11
Figure 4: ENT Devices, North America, Overall Revenue ($m), USD Constant, Historic, 2004-2011 12
Figure 5: ENT Devices, North America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 14
Figure 6: ENT Devices, North America, Company share (%), 2011 16
Figure 7: ENT Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018 18
Figure 8: ENT Devices, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011 19
Figure 9: ENT Devices, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 21
Figure 10: ENT Devices, United States, Company Share (%), 2011 26
Figure 11: Diagnostic Devices, United States, Company Share (%), 2011 28
Figure 12: Hearing Aid Devices, United States, Company Share (%), 2011 30
Figure 13: Hearing Implants, United States, Company Share (%), 2011 32
Figure 14: Voice Prosthesis, United States, Company Share (%), 2011 33
Figure 15: ENT Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018 34
Figure 16: ENT Devices, Canada, Overall Revenue ($m), USD Constant, Historic, 2004-2011 36
Figure 17: ENT Devices, Canada, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 38
Figure 18: ENT Devices, Canada, Company Share (%), 2011 43
Figure 19: Diagnostic Devices, Canada, Company Share (%), 2011 45
Figure 20: Hearing Aid Devices, Canada, Company Share (%), 2011 47
Figure 21: Hearing Implants, Canada, Company Share (%), 2011 49
Figure 22: Voice Prosthesis, Canada, Company Share (%), 2011 50
Figure 23: William Demant Holding A/S, Company Share (%), North America ENT Devices Market, 2011 51
Figure 24: Starkey Hearing Technologies, Inc., Company Share (%), North America ENT Devices Market, 2011 52
Figure 25: Sonova Holding AG, Company Share (%), North America ENT Devices Market, 2011 53
Figure 26: Siemens Healthcare, Company Share (%), North America ENT Devices Market, 2011 54
Figure 27: Cochlear Limited, Company Share (%), North America ENT Devices Market, 2011 55
Figure 28: GN ReSound A/S, Company Share (%), North America ENT Devices Market, 2011 56

Companies mentioned
William Demant Holding A/S
Starkey Hearing Technologies, Inc.
Sonova Holding AG
Siemens Healthcare
Cochlear Limited
GN ReSound A/S
Widex A/S
MED-EL
Natus Medical Incorporated
Welch Allyn Inc.
Atos Medical AB
InHealth

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

  • $ 34 500
  • Industry report
  • July 2014
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 800
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of majo ...

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.